Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe.

OBJECTIVES Co-trimoxazole (trimethoprim/sulfamethoxazole) is clinically valuable in treating skin and soft tissue infections (SSTIs) caused by community-associated methicillin-resistant Staphylococcus aureus (MRSA). The genetic basis of emerging trimethoprim/sulfamethoxazole resistance in S. aureus from Africa is unknown. Such knowledge is essential to anticipate its further spread. We investigated the molecular epidemiology of trimethoprim resistance in S. aureus collected in and imported from Africa. METHODS Five hundred and ninety-eight human S. aureus isolates collected at five locations across sub-Saharan Africa [Gabon, Namibia, Nigeria (two) and Tanzania] and 47 isolates from travellers treated at six clinics in Europe because of SSTIs on return from Africa were tested for susceptibility to trimethoprim, sulfamethoxazole and trimethoprim/sulfamethoxazole, screened for genes mediating trimethoprim resistance in staphylococci [dfrA (dfrS1), dfrB, dfrG and dfrK] and assigned to spa genotypes and clonal complexes. RESULTS In 313 clinical and 285 colonizing S. aureus from Africa, 54% of isolates were resistant to trimethoprim, 21% to sulfamethoxazole and 19% to trimethoprim/sulfamethoxazole. We found that 94% of trimethoprim resistance was mediated by the dfrG gene. Of the 47 S. aureus isolates from travellers with SSTIs, 27 (57%) were trimethoprim resistant and carried dfrG. Markers of trimethoprim resistance other than dfrG were rare. The presence of dfrG genes in S. aureus was neither geographically nor clonally restricted. CONCLUSIONS dfrG, previously perceived to be an uncommon cause of trimethoprim resistance in human S. aureus, is widespread in Africa and abundant in imported S. aureus from ill returning travellers. These findings may foreshadow the loss of trimethoprim/sulfamethoxazole for the empirical treatment of SSTIs caused by community-associated MRSA.

[1]  C. Lacroix,et al.  Tn6198, a novel transposon containing the trimethoprim resistance gene dfrG embedded into a Tn916 element in Listeria monocytogenes. , 2013, The Journal of antimicrobial chemotherapy.

[2]  Herman Goossens,et al.  Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. , 2013, The Lancet. Infectious diseases.

[3]  A. Seck,et al.  Epidemiology of Staphylococcus aureus in pigs and farmers in the largest farm in Dakar, Senegal. , 2012, Foodborne pathogens and disease.

[4]  O. Ojurongbe,et al.  Clonal expansion accounts for an excess of antimicrobial resistance in Staphylococcus aureus colonising HIV-positive individuals in Lagos, Nigeria. , 2012, International journal of antimicrobial agents.

[5]  S. Schwarz,et al.  Novel and uncommon antimicrobial resistance genes in livestock-associated methicillin-resistant Staphylococcus aureus. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  A. Anderson,et al.  Prospective Screening of Novel Antibacterial Inhibitors of Dihydrofolate Reductase for Mutational Resistance , 2012, Antimicrobial Agents and Chemotherapy.

[7]  C. Wolz,et al.  Import and spread of Panton-Valentine Leukocidin-positive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Onanuga,et al.  Nasal carriage of multi-drug resistant Staphylococcus aureus in healthy inhabitants of Amassoma in Niger delta region of Nigeria. , 2011, African health sciences.

[9]  E. Tacconelli,et al.  Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  U. Nübel,et al.  Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria , 2011, BMC Microbiology.

[11]  P. Boisier,et al.  Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  B. Appel,et al.  Virulence and Resistance Determinants of German Staphylococcus aureus ST398 Isolates from Nonhuman Sources , 2011, Applied and Environmental Microbiology.

[13]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  B. Duim,et al.  Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. , 2010, The Journal of antimicrobial chemotherapy.

[15]  F. DeLeo,et al.  Community-associated meticillin-resistant Staphylococcus aureus , 2010, The Lancet.

[16]  A. Anderson,et al.  Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase. , 2010, Journal of structural biology.

[17]  J. Lasarte,et al.  Skin Lesion Caused by ST398 and ST1 MRSA, Spain , 2010, Emerging infectious diseases.

[18]  M. Quail,et al.  Genome Sequence of a Recently Emerged, Highly Transmissible, Multi-Antibiotic- and Antiseptic-Resistant Variant of Methicillin-Resistant Staphylococcus aureus, Sequence Type 239 (TW) , 2009, Journal of bacteriology.

[19]  W. König,et al.  Emergence of a Community-Associated Methicillin-Resistant Staphylococcus aureus Strain with a Unique Resistance Profile in Southwest Nigeria , 2009, Journal of Clinical Microbiology.

[20]  P. Caspers,et al.  In Vitro and In Vivo Properties of Dihydrophthalazine Antifolates, a Novel Family of Antibacterial Drugs , 2009, Antimicrobial Agents and Chemotherapy.

[21]  B. Lyon,et al.  Genetics of antimicrobial resistance in Staphylococcus aureus. , 2009, Future microbiology.

[22]  C. Oefner,et al.  Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity. , 2009, The Journal of antimicrobial chemotherapy.

[23]  S. Schwarz,et al.  Identification of a Novel Trimethoprim Resistance Gene, dfrK, in a Methicillin-Resistant Staphylococcus aureus ST398 Strain and Its Physical Linkage to the Tetracycline Resistance Gene tet(L) , 2008, Antimicrobial Agents and Chemotherapy.

[24]  H. Zar,et al.  High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa , 2008, BMC infectious diseases.

[25]  J. Stoye,et al.  Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms , 2007, BMC Microbiology.

[26]  N. Sneige,et al.  Author reply , 2007 .

[27]  T. Kirikae,et al.  Cloning and Characterization of a Novel Trimethoprim-Resistant Dihydrofolate Reductase from a Nosocomial Isolate of Staphylococcus aureus CM.S2 (IMCJ1454) , 2005, Antimicrobial Agents and Chemotherapy.

[28]  J. Rothgänger,et al.  Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management , 2003, Journal of Clinical Microbiology.

[29]  M. Page,et al.  Structure and function of the dihydropteroate synthase from Staphylococcus aureus. , 1997, Journal of molecular biology.

[30]  M. Page,et al.  A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. , 1997, Journal of molecular biology.

[31]  D. Rouch,et al.  Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257 , 1989, Molecular microbiology.

[32]  J. L. Johnston,et al.  Plasmid-encoded trimethoprim resistance in staphylococci , 1986, Antimicrobial Agents and Chemotherapy.

[33]  M. Tanner,et al.  Staphylococcal disease in Africa: another neglected 'tropical' disease. , 2013, Future microbiology.

[34]  D. Paterson,et al.  Increases in Australian cutaneous abscess hospitalisations: 1999–2008 , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[35]  F. Laurent,et al.  Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Guangqi Li,et al.  Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus(MRSA) infections presenting in the community , 2008 .

[37]  Anne M Johnson,et al.  Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. , 2008, Emerging infectious diseases.